中新社北京7月30日电 (记者 蒋雪林)天津大学药学院循证药物经济学评价研究中心主任孙鹤教授近日表示，中药要走向世界需加强药物经济学研究。

Arriving on July 30, Beijing (Reporter JiangXueLin)Tianjin university college of pharmacy evidence-based medicine economic evaluation of the research centre SunHe professor said recently，Traditional Chinese medicine go toward the world need to strengthen drug economics。

　　他是在中国国家中医药管理局科技司主办的“实证药物经济学研究与中药产业发展研讨会”上做上述表示的，该研讨会近日在北京举行。

He is in China sponsored by the state administration of traditional Chinese medicine slurry“The empirical economic research and drug industry of Chinese development forum”The above said on，The conference recently held in Beijing。

　　“如果能在中药的临床研究工作中引入药物经济学的评价指标，或许能让纠结我们几十年的困惑豁然开朗，也能促使中药迈出国门、走向世界。”孙鹤说。

“If the clinical research in Chinese traditional medicine can work into drug evaluation indexes of economics，Perhaps we can make entanglements decades of confused suddenly enlightened，Can also prompted Chinese medicine taken abroad、Towards the world。”SunHe said。

　　孙鹤介绍，药物经济学可以归纳为：利用现代经济学基本原理、方法和分析技术，结合流行病学、决策学、生物统计学等学科知识，全方位地分析药物治疗备选方案的成本、效益、效果或效用，并以药物流行病学的人群观为指导，从全社会角度开展研究，为临床合理用药和制定最佳的疾病防治措施提供科学依据，以求最大限度地合理利用现有医药卫生资源的综合性应用科学。

SunHe introduced，Drugs can be summarized as economics：Use of modern economics basic principle、Method and analyzing technology，Combining epidemiological、Decision learn、Biostatistics disciplines such as knowledge，Comprehensive analysis of drug treatment options costs、benefit、Effect or utility，And the crowd with drugs epidemiology view of guidance，From the Angle of social research，For clinical rational drug use and make the best of disease prevention and control measures to provide the scientific basis，In order to maximize the reasonable utilization of existing medical health resources comprehensive application science。

　　“作为中国国粹的中药，因其组分、成分的复杂性以及评价结果的不准确性，中药的药物经济学评价进展程度并不乐观。”孙鹤说。

“As China's the quintessence of Chinese traditional medicine，Because of its components、The complexity of the ingredients and the result of evaluation not accuracy，Traditional Chinese medicine drugs economic evaluation progress is not optimistic。”SunHe said。

　　在该研讨会上，中国国家中医药管理局副局长李大宁表示，中医药要走向国际，实际上涉及是定价权的问题。定价权是中药扩展国际市场，产生经济效益，为国家的经济利益做出贡献当中的一个非常重要的问题。我们如何说服国际商家和管理部门认可我们的产品？我们还缺少一个有利的理论武器。“所以我认为，加强中药药物经济学研究非常重要。”

In this conference，China's state administration of traditional Chinese medicine, deputy director of the LiDaNing said，Traditional Chinese medicine to to go into the international，In fact the problem of pricing is involved。Pricing is Chinese traditional medicine expand international market，Produce economic benefits，For the country's economic interests of contribute a very important question。How can we persuade international business and management department approved our product？We still lack a favorable theory weapons。“So I think，Strengthen traditional Chinese medicine research is important drug economics。”

　　北京博诺威药物经济学研究中心主任王昕认为，中医药研究面临几个挑战：一是中医医院越来越多地采用西医指南，因此中药评价不仅需要头对头的比较，还需要评价西药基础上联合中药的疗效变化，因此需要做药物经济学评价。

Beijing bono, director of the center for economic research's drug WangXin think，Traditional Chinese medicine research face several challenges：A traditional Chinese medicine hospital is used more and more western medicine guide，So the Chinese traditional medicine needs not only the head of the evaluation adversary comparison，Western medicine is required to assess the curative effect of traditional Chinese medicine based on joint changes，Therefore need to do drugs economic evaluation。

　　据悉，天津大学药学院药政法规与转化医学研究中心、循证药物经济学评价研究中心联合博诺威药物经济学研究中心，在有关管理部门领导的大力支持下，参考世界各国药物经济学指南及研究进展，对中药开展药物经济学评价面临的一系列问题和挑战进行了长期、广泛、深入研究后，共同开展了《中药药物经济学研究规范》(草案)的制定工作。

It is reported，Tianjin university college of pharmacy drug laws and regulations and transformation medical research center、Evidence-based medicine economic evaluation research center's joint bono drug economics research center，In the relevant administrative departments under the support of leadership，Reference guide to the countries all over the world economics research progress and drugs，The traditional Chinese medicine in drug economic evaluation of a series of problems and challenges facing the long-term、widely、After further research，Jointly held the《Traditional Chinese medicine drugs economics norms》(draft)Formulation of。

　　王昕透露，博诺威药物经济学研究中心已完成全球33个国家和地区的药物经济学指南的比较研究，并已开展多项中药药物经济学临床评价工作。王昕认为，在当前医疗环境中，鉴于多数慢性疾病的治疗都是复杂干预，治疗方案和治疗路径越来越多地参考国内外各种治疗指南，使得中药药物经济学评价的设计和实施面临诸多现实挑战，需要考虑更多因素，设计更加复杂，在设计阶段就要对大量的临床实际问题和各地医疗卫生政策的差异对结果的影响进行充分研究和评估。《中药药物经济学研究规范》(草案)的出台，为以后的研究提供了很好的参考。(完)

WangXin revealed，Bono's drug economics research center has completed the global 33 countries and regions of comparative study of drug economics guidelines，And has set up a file in Chinese medicine clinical evaluation many drug economics。WangXin think，In the current medical environment，In view of the most chronic disease of therapy are complex intervention，Treatment plan and treatment path more and more reference guide for treatment of all kinds at home and abroad，Make Chinese medicine drugs economic evaluation of the design and implementation of the challenges facing many reality，Need to consider more factors，Design is more complex，In the design phase of a large number of clinical to practical problems and from all the medical and health policy differences on the influence of the full study and evaluation。《Traditional Chinese medicine drugs economics norms》(draft)Come on stage，For the following provides a good reference。(finish)